U.S. Subsidiary – EG BioMed US
EG BioMed US was established in Washington State, USA, in 2024, and is certified under the CLIA (Clinical Laboratory Improvement Amendments) regulations. It provides regulatory-compliant shared laboratory services for biotech companies aiming to enter the U.S. market, accelerating innovations in precision medicine, raising health awareness, and supporting businesses in expanding their global market presence.


